MedTrace Logo

Impact of the PREEMI Package on Neonatal Mortality

NCT03923023 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11195

Last updated 2022-05-09

No results posted yet for this study

Summary

The purpose of this Quality Improvement initiative is to reduce severe morbidity and mortality among premature infants through proven and cost-effective clinical management during the antenatal, intrapartum, and postpartum periods. In order to reduce neonatal mortality and morbidity due to preterm birth complications, health facilities must be able to identify and manage women in preterm labor, accurately administer medications, and provide high-quality postnatal care.

Conditions

Sponsors & Collaborators

  • Centre for Infectious Disease Research in Zambia

    collaborator OTHER

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Albert Manasyan, MD, MPH · University of Alabama at Birmingham

Eligibility

Min Age
10 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-01
Primary Completion
2017-10-31
Completion
2018-06-30

Countries

  • Zambia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03923023 on ClinicalTrials.gov